Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome

Update Il y a 4 ans
Reference: NCT00815659

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to evaluate the efficacy of rosuvastatin therapy on plasma lipid profile (Low Density Lipoprotein (LDL), High-Density Lipoprotein (HDL), total cholesterol, triglyceride) in patients with metabolic syndrome.


Inclusion criteria

  • Metabolic syndrome

Links